Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arrhythmia
Research reports on arrhythmia from D. Katritsis and colleagues provide new insights
August 25th, 2008
"Clinical and experimental studies have demonstrated the proarrhythmic potential of skeletal myoblast transplantation for repair of infarcted myocardium," scientists in Athens, Greece report. "The evidence on proarrhythmia following bone marrow-derived stem cells, and particular msenchymal stem cells, transplantation is inconclusive. There are experimental and preliminary clinical data supporting the possibility that mesenchymal stem cell transplantation might exert an anti-arrhythmic action by intervening with myocardial scar remodeling," wrote D. Katritsis and colleagues. The researchers concluded: "However, clinical experience is limited." ...
Source: Stem Cell Week (2008-08-25)
|
